Pharmaceutical and biopharma companies are required by regulatory compulsions to implement a pharmacovigilance/drug safety surveillance programme and monitor the safety profiles of their marketed ...

Pharmaceutical case processing is witnessing a 15% annual increase in adverse event reports, according to FDA statistics. Over the last decade the industry has exhausted resourcing to low-cost ...

This week's Expert View, from Uwe Trinks, global practice lead for pharmacovigilance tech at IQVIA, examines the use of new artificial intelligence-based tools to improve pharmacovigilance. The ...

Case management, no matter the type of case, provides an opportunity for a productivity-clogging backlog. You have a pipeline into which new cases are entered while current cases remain open in ...